Locations:
SearchAdvertisement
New research explores the role of immune cell and blood-brain barrier changes
Open-source artificial intelligence technology uses human genetic data to find candidate drugs
Experts weigh in on the amyloid hypothesis and how to use lecanemab if approved
Findings underscore need for racial diversity in ongoing and future trials
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Investigative highlights include hormone therapies, biomarkers and early lifestyle interventions
An expert reviews risk factors and prevention strategies specific to women
Cognitive phenotypes are related to behavioral changes in Alzheimer’s and Lewy body dementia
Risk of agitation, delusions, personality change and more is shaped by early presentation
69% relative risk reduction in large database analysis prompts plans for mechanistic and phase 2 studies
$15.4M grant to fund work on atypical Alzheimer’s, Lewy body dementia and more
Advertisement
Advertisement